NCT01641237

Brief Summary

The proposed study will evaluate the performance of fluoride delivered from a new dentifrice formulation without potassium nitrate. It will also evaluate the dose-response to fluoride by testing four dentifrices covering a range of sodium fluoride concentration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Mar 2012

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 12, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 16, 2012

Completed
1 year until next milestone

Results Posted

Study results publicly available

July 31, 2013

Completed
Last Updated

July 24, 2014

Status Verified

June 1, 2014

Enrollment Period

2 months

First QC Date

July 12, 2012

Results QC Date

May 30, 2013

Last Update Submit

July 17, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage Surface Microhardness Recovery (%SMHR) Dose Response Relationship

    SMHR test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMHR was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMHR was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: \[(E1-R)/ (E1-B)\]\*100.

    Baseline to 4 hours

Secondary Outcomes (3)

  • %SMHR

    Baseline to 4 hours

  • Percentage Relative Erosion Resistance

    Baseline to 4 hours

  • Enamel Fluoride Uptake (Corrected Data)

    Baseline to 4 hours

Study Arms (4)

Low ppm fluoride dentifrice

EXPERIMENTAL

Low ppm fluoride as sodium fluoride in a silica base dentifrice

Drug: sodium fluoride

Medium ppm fluoride dentifrice

EXPERIMENTAL

Medium ppm fluoride as sodium fluoride in a silica base dentifrice

Drug: sodium fluoride

High ppm fluoride dentifrice

EXPERIMENTAL

High ppm fluoride as sodium fluoride in a silica base dentifrice

Drug: sodium fluoride

No fluoride dentifrice

PLACEBO COMPARATOR

no added fluoride in a silica base dentifrice

Drug: no added fluoride in a silica base

Interventions

fluoride as sodium fluoride

High ppm fluoride dentifriceLow ppm fluoride dentifriceMedium ppm fluoride dentifrice

no added fluoride

No fluoride dentifrice

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • intact maxillary dental arch suitable to retain a palatal appliance, an intact mandibular dental arch and a stimulated/unstimulated saliva flow rate of ≥ 0.8 milliliter/minute (ml/min) and ≥ 0.2 ml/min respectively.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University School of Dentistry

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Interventions

Sodium Fluoride

Intervention Hierarchy (Ancestors)

FluoridesHydrofluoric AcidFluorine CompoundsInorganic ChemicalsSodium CompoundsCariostatic AgentsBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Results Point of Contact

Title
GSK Response Center
Organization
GlaxoSmithKline

Study Officials

  • GSK Clinical Trials

    GlaxoSmithKline

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2012

First Posted

July 16, 2012

Study Start

March 1, 2012

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

July 24, 2014

Results First Posted

July 31, 2013

Record last verified: 2014-06

Locations